NCT01387217View on ClinicalTrials.gov

GSK2018682 FTIH in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

May 21, 2010

Primary Completion Date

December 20, 2010

Study Completion Date

December 20, 2010

Conditions

Multiple Sclerosis

Interventions

DRUG

GSK2018682

GSK2018682

DRUG

Placebo

Matched Placebo

Trial Locations (2)

2031

GSK Investigational Site, Randwick

5000

GSK Investigational Site, Adelaide

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01387217 - GSK2018682 FTIH in Healthy Volunteers | Biotech Hunter | Biotech Hunter